Filter your results
- 3
- 1
- 4
- 1
- 4
- 1
- 1
- 2
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
4 Results
|
|
sorted by
|
|
Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximabPharmacogenomics, 2015, 16 (18), pp.2035-2043. ⟨10.2217/pgs.15.139⟩
Journal articles
hal-02381189v1
|
||
|
ADAM17-Mediated Shedding of FcγRIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with ActivationJournal of Immunology, 2014, 192 (2), pp.741-751. ⟨10.4049/jimmunol.1301024⟩
Journal articles
hal-02389220v1
|
||
|
Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non-metastatic breast cancerBritish Journal of Clinical Pharmacology, 2016, 81 (5), pp.941-948. ⟨10.1111/bcp.12875⟩
Journal articles
hal-01252102v1
|
||
|
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mousemAbs, 2014, 6 (4), pp.1026 - 1037. ⟨10.4161/mabs.28699⟩
Journal articles
hal-01680794v1
|